Catalyst Funds Management Pty LTD Biodesix Inc Transaction History
Catalyst Funds Management Pty LTD
- $662 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding BDSX
# of Institutions
9Shares Held
1.11MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY416KShares$3.33 Million0.0% of portfolio
-
Birchview Capital, LP Burlington, VT287KShares$2.29 Million1.72% of portfolio
-
Cannell & Co. New York, NY206KShares$1.64 Million0.01% of portfolio
-
Allworth Financial LP99.3KShares$794,6480.0% of portfolio
-
Ajo Vista, LLC Boston, MA45.1KShares$360,9920.35% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $320M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...